{"product_id":"b7h4-antibody-sc-f3059","title":"B7-H4 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eB7H4 is a target of interest in many antibody-based workflows. B7-H4 is an immune checkpoint molecule and a type I transmembrane protein in the B7 family that inhibits T cell activation and promotes tumor progression. Structurally, it consists of two extracellular Ig-like domains, a hydrophobic transmembrane domain, and a short intracellular region. B7-H4 is predominantly expressed on cancer cells and tumor-associated macrophages (TAMs), with minimal expression in normal tissues. Depending on the literature source, B7H4 may also be discussed as B7-H4.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane and membrane, which can matter when signal is compared across treatments or changing cell states. Following B7H4 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eB7H4 is commonly interpreted in the context of cancer, immunology, and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane and membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for B7H4. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in B7H4 reflect biology rather than handling. When interpreting B7H4, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep B7H4 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578001498457,"sku":"F3059-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578001531225,"sku":"F3059-100UL","price":459.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578001563993,"sku":"F3059-2X100UL","price":689.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3059-wb.gif?v=1773600918","url":"https:\/\/absource.de\/products\/b7h4-antibody-sc-f3059","provider":"Absource Diagnostics","version":"1.0","type":"link"}